Takeda Pharmaceutical Company Limited Payments To Acquire Or Redeem Entitys Shares
Takeda Pharmaceutical Company Limited (TKPHF) reported Payments To Acquire Or Redeem Entitys Shares of JPY 51.86 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Cash Flow › Investing Activities
ifrs-full:PaymentsToAcquireOrRedeemEntitysShares · last filed 2025-06-25
| Period end | Payments To Acquire Or Redeem Entitys Shares 12 month |
|---|---|
| 2025-03-31 | 51.86B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 2.33B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 26.93B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 77.53B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 2.14B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 3.74B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | 1.17B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 18.76B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 23.12B JPY 20-F · filed 2019-06-27 |